ESSA PHARMA INC's ticker is and the CUSIP is 29668H104. A total of 10 filers reported holding ESSA PHARMA INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $792,000 | -92.5% | 1,440,269 | -57.6% | 0.14% | -85.9% |
| Q1 2017 | $10,590,000 | +185.0% | 3,393,936 | +100.0% | 0.99% | +35.8% |
| Q4 2016 | $3,716,000 | -22.3% | 1,696,968 | 0.0% | 0.73% | -16.9% |
| Q3 2016 | $4,785,000 | -4.4% | 1,696,968 | 0.0% | 0.88% | -18.0% |
| Q2 2016 | $5,006,000 | -9.2% | 1,696,968 | 0.0% | 1.07% | -7.6% |
| Q1 2016 | $5,515,000 | +65.1% | 1,696,968 | +133.3% | 1.16% | +76.3% |
| Q4 2015 | $3,340,000 | -26.6% | 727,272 | 0.0% | 0.66% | -25.5% |
| Q3 2015 | $4,552,000 | – | 727,272 | – | 0.88% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 1,084,848 | $4,122,000 | 3.04% |